Research

Energy balance

The uptake of obesity treatments remains disproportionally low in people living with the disease.

Healthcare providers should be aware of the low uptake to better engage patients in treatment options.

StrongSupportsmedium confidence
The uptake of obesity treatments remains disproportionally low in people living with the disease, even with the advent and availability of GLP-1 agonists in recent years.
E. P. Farrell et al. · Obesity Pillars · 2024

Why this rating

Based on qualitative study design with focus groups.

Source

“What would be left of me?” Patient perspectives on the risks of obesity treatment: An innovative health initiative stratification of obesity phenotypes to optimise future obesity therapy (IMI2 SOPHIA) qualitative study

E. P. Farrell et al. · Obesity Pillars · 2024

DOI 10.1016/j.obpill.2024.100129

qualitative study · n=30Cited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →